Elsevier

Neuropharmacology

Volume 154, August 2019, Pages 96-106
Neuropharmacology

The effect of acute or repeated stress on the corticotropin releasing factor system in the CRH-IRES-Cre mouse: A validation study

https://doi.org/10.1016/j.neuropharm.2018.09.037Get rights and content

Highlights

  • The Crh-IRES-Cre::Ai14 mouse had faithful reporter expression in BNST and PVN.

  • The Crh-IRES-Cre::Ai14 mouse had unfaithful reporter expression in PVT and LH.

  • Acute stress stimulated Fos expression in PVN CRF neurons.

  • Chronic stress followed by a novel acute stressor did not recruit CRF neurons.

Abstract

Corticotropin releasing factor (CRF) is a key component of stress responsivity, modulating related behaviors including anxiety and reward. Difficulties identifying CRF neurons, using traditional approaches including immunohistochemistry, has led to the development of a number of transgenic CRF reporter mice. The Crh-IRES-Cre::Ai14 (tdTomato) reporter mouse is increasing in popularity as a useful tool to assess the localization, connectivity and function of CRF neurons in various stress-related behaviors. However, without proper characterization of reporter expression, the in vivo and in vitro manifestations resulting from the manipulation of these cells must be interpreted with caution. Here we mapped the distribution of tdTomato-expressing CRF cells throughout the rostro-caudal extent of the Crh-IRES-Cre::Ai14 mouse brain. To determine if reporter expression faithfully reproduced native CRF expression, we assessed the colocalization of CRF expression with tdTomato reporter expression across several brain regions. Good concordance was observed in the extended amygdala and paraventricular nucleus of the hypothalamus (PVN), while discrepancies were observed within the lateral hypothalamus and hippocampus. Finally, we examined the activation of CRF neurons in Crh-IRES-Cre::Ai14 mice in response to different types of stressors using Fos immunohistochemistry. Acute psychological (swim) and pharmacological (yohimbine) stress stimulated Fos-protein expression in PVN CRF neurons. Interestingly though, exposure to four daily restraint stress sessions followed by a novel acute stressor did not further recruit CRF neurons across any brain region examined. Our results highlight the importance of thoroughly characterizing reporter mice before use and suggest that acute versus repeated stress may differentially impact the CRF system.

This article is part of the Special Issue entitled ‘Hypothalamic Control of Homeostasis’.

Introduction

Corticotropin releasing factor (CRF) is a key brain mediator of stress-related behaviors. A disruption in homeostasis of the CRF system has been linked to a variety of stress-related psychiatric disorders including depression, anxiety and addiction, all of which involve altered emotional states (Nemeroff et al., 1984, Henckens et al., 2016, Koob and Volkow, 2016). Manipulation of the CRF gene promoter has been accomplished using a variety of technologies, including bacterial artificial chromosome (BAC) transgenics (Alon et al., 2009) and genetic targeting (e.g. knock-in) (Kono et al., 2017), such as IRES-Cre (Taniguchi et al., 2011). The Crh-IRES-Cre mouse has been bred with several reporter lines including Ai3 (GFP) Ai9 and Ai14 (tdTomato), to generate mice with visualizable CRF-expressing cells (Wamsteeker Cusulin et al., 2013, Chen et al., 2015, Hooper and Maguire, 2016, Martin et al., 2010, Peng et al., 2017, Dedic et al., 2018). These neuronal populations are easily available for anatomical and morphological examination as well as electrophysiology and/or optogenetic/chemogenetic manipulation.

A major obstacle in identifying CRF neurons has historically been due to the difficulty in CRF peptide detection by immunohistochemistry using anti-CRF antibodies without additional tools, such as colchicine pre-treatment (Gunn et al., 2013, Borisy and Taylor, 1967). Colchicine is toxic at typically employed doses, leading to physical stress and neuronal activation in stress-related brain regions (Ceccatelli et al., 1989). The recent development of the Crh-IRES-Cre mouse has allowed for examination and manipulation of the CRF system and is emerging as a useful tool to examine the role of the mouse CRF system in stress-associated behaviors (Wamsteeker Cusulin et al., 2013, Dedic et al., 2018, Füzesi et al., 2016, Kondoh et al., 2016, Partridge et al., 2016). Recent studies have examined the validity of reporter expression in several key brain regions of the Crh-IRES-Cre::Ai14 and Crh-IRES-Cre::Ai9 mouse, including the bed nucleus of the stria terminalis (BNST), paraventricular nucleus of the hypothalamus (PVN), hippocampus and central nucleus of the amygdala (CeA) (Wamsteeker Cusulin et al., 2013, Chen et al., 2015, Dedic et al., 2018). Additionally, a recent study has mapped global reporter expression in the Crh-IRES-Cre::Ai3 mouse (Peng et al., 2017). However, some studies suggest that mouse lines crossed to different reporter lines show reporter expression in distinct populations or subpopulations within specific brain regions (Hooper and Maguire, 2016). For example, crossing of the BAC CRF-Cre line to either a tdTomato or mTomato-GFP reporter line led to labelling of anatomically distinct neuronal populations within the hippocampus (Hooper and Maguire, 2016). Therefore, as the Crh-IRES-Cre::Ai14 mouse has emerged as a popular mouse line to assess and manipulate the CRF system, further mapping and validation of expression is required. Thus, we mapped the distribution of tdTomato reporter in the Crh-IRES-Cre::Ai14 mouse and assessed the concordance of CRF protein and reporter expression throughout select brain regions.

Key to the role of CRF in stress responsivity is the hypothalamic–pituitary–adrenal (HPA) axis (Herman and Cullinan, 1997). CRF is released into the periphery from the PVN and directly activates the HPA axis by triggering the release of adrenocorticotropic hormone (ACTH) from the anterior pituitary, which in turn stimulates the synthesis and secretion of glucocorticoids from the adrenal gland (Vale et al., 1981). Central administration of CRF induces anxiety-like behavior in the conflict, social interaction, acoustic startle and elevated plus maze tests (Swerdlow et al., 1986, Dunn and File, 1987, File et al., 1988). Further, both physical and psychological stressors activate CRF PVN neurons (Dayas et al., 2001). CRF is also located outside the PVN to control autonomic and behavioral responses to stress. For example, CRF-like-immunoreactivity is present in the neocortex, medial prefrontal cortex (mPFC), BNST, amygdala, medial septum, hypothalamus, thalamus, cerebellum, midbrain and hindbrain nuclei (Swanson et al., 1983). Additionally, the amygdala is thought to play a primary role in mediating anxiety-like responses (Davis et al., 2003). Regulatory dysfunction in the amygdala can lead to an abnormal pattern of affective responses and the development of recurring emotional disorders such as anxiety, depression and addiction (Gilpin et al., 2015).

Previous research has shown that distinct stressors can differentially modulate CRF expression and neural activation (See McReynolds et al., 2018 for review). For example, chronic unpredictable stress, but not acute restraint stress, increases CRF-like-immunoreactivity within the periventricular nucleus and anterior hypothalamic nucleus (Chappell et al., 1986). Additionally, acute, but not chronic, stress decreases CRF-like-immunoreactivity within the medial preoptic area (MPO) (Chappell et al., 1986). The specific pattern of activation of CRF neurons following acute and repeated psychological and pharmacological stress in mouse models remains uncharacterized. Here we examined the activation of CRF neurons in hypothalamic and extrahypothalamic brain regions following exposure to acute psychological (forced swim) and pharmacological (yohimbine) stressors in mice with and without a history of repeated restraint stress.

Section snippets

Animals

All studies were performed in accordance with the Prevention of Cruelty to Animals Act (2004), under the guidelines of the National Health and Medical Research Council Code of Practice for the Care and Use of Animals for Experimental Purposes in Australia (2013) and approved by The Florey Animal Ethics Committee. B6(Cg)-Crhtm1(cre)Zjh/J (Crh-IRES-Cre) mice and B6.Cg-Gt(ROSA)26Sortm14(CAG−TdTomato)Hze/J (Ai14) mice were obtained from The Jackson Laboratory (Bar Harbor, ME, USA; stock numbers

Crh-IRES-Cre::Ai14 distribution map

The distribution of tdTomato-expressing CRF cells was examined throughout the entire brain of male and female Crh-IRES-Cre::Ai14 mice. The density of tdTomato expression (per mm2) and % tdTomato-positive DAPI cells were quantified in 65 brain regions (summarized in Fig. 1 and Fig. 2). Two-way ANOVA showed a main effect of region for both tdTomato density (F(64,224) = 106.4, p < 0.001) and % tdTomato-positive DAPI cells (F(64,224) = 44.38, p < 0.001), but no effect of sex on density (F(1,224)

Discussion

CRF has a well-known role in stress responsivity, however, it is also involved in normal and pathological cognitive and emotional states including learning and memory (Nemeroff et al., 1984, Heim et al., 2009, Koob and Volkow, 2016). In this study, we examined the distribution of tdTomato-expressing CRF cells throughout the Crh-IRES-Cre::Ai14 mouse brain and reporter concordance with CRF peptide expression in selected brain regions. Further, we utilized the Crh-IRES-Cre::Ai14 mouse to examine

Funding and disclosure

All authors report no conflict of interest.

This work was supported by a National Health and Medical Research Council Project Grant to AJL (1079893). AJL is a National Health and Medical Research Council Principal Fellow (1116930). LCW is supported by the Australian Government Research Training Program Scholarship. EJC is supported by the University of Melbourne Early Career Researcher Grant Scheme. We acknowledge the Victorian State Government Operational Infrastructure Scheme.

Author contributions

LCW, EJC and AJL designed the study; LCW, EJC, and LC conducted all experiments; LCW and EJC conducted analyses; and LCW, EJC and AJL wrote the manuscript. All authors reviewed the content and approved the final version of the manuscript.

Data accessibility

For additional information on data analysis or generation, please contact the corresponding author.

Acknowledgements

We thank Dr. Sarah Ch'ng and Dr. Craig Smith for their technical assistance; Dr Wylie W. Vale (in memoriam), Dr Paul E. Sawchenko and Dr Joan Vaughan from the Salk Institute for Biological Studies for their generous gift of the antisera against CRF (PBL#C70).

References (48)

  • S. Pellow et al.

    Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

    J. Neurosci. Meth.

    (1985)
  • J. Peng et al.

    A quantitative analysis of the distribution of CRH neurons in whole mouse brain

    Front. Neuroanat.

    (2017)
  • H. Taniguchi et al.

    A resource of Cre driver lines for genetic targeting of GABAergic neurons in cerebral cortex

    Neuron

    (2011)
  • G.F. Alheid

    Extended amygdala and basal forebrain

    Ann. N. Y. Acad. Sci.

    (2003)
  • T. Alon et al.

    Transgenic mice expressing green fluorescent protein under the control of the corticotropin-releasing hormone promoter

    Endocrinology

    (2009)
  • G.G. Borisy et al.

    The mechanism of action of colchicine

    J. Cell Biol.

    (1967)
  • S. Ceccatelli et al.

    Expression of c-Fos immunoreactivity in transmitter-characterized neurons after stress

    Proc. Natl. Acad. Sci. U.S.A.

    (1989)
  • P. Chappell et al.

    Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress

    J. Neurosci.

    (1986)
  • Y. Chen et al.

    Diversity of reporter expression patterns in transgenic mouse lines targeting corticotropin-releasing hormone-expressing neurons

    Endocrinology

    (2015)
  • M. Davis et al.

    Role of the amygdala in fear extinction measured with potentiated startle

    Ann. N. Y. Acad. Sci.

    (2003)
  • C.V. Dayas et al.

    Stressor categorization: acute physical and psychological stressors elicit distinctive recruitment patterns in the amygdala and in medullary noradrenergic cell groups

    Eur. J. Neurosci.

    (2001)
  • N. Dedic et al.

    Chronic CRH depletion from GABAergic, long-range projection neurons in the extended amygdala reduces dopamine release and increases anxiety

    Nat. Neurosci.

    (2018)
  • S.E. File et al.

    Anxiolytic and anxiogenic drugs: changes in behaviour and endocrine responses

    Stress Health

    (1988)
  • D. Funk et al.

    Effects of prazosin and doxazosin on yohimbine-induced reinstatement of alcohol seeking in rats

    Psychopharmacology

    (2016)
  • Cited by (31)

    • Alterations in the activation of corticotropin-releasing factor neurons in the paraventricular nucleus following a single or multiple days of sleep restriction

      2023, Neuroscience Letters
      Citation Excerpt :

      All CRF:tdTomato mice were bred in house by crossing B6(Cg)-Crhtm(Cre)Zjh/J (CRF-IRES-Cre; RRID: IMSR_JAX: 012704; stock no. 012704; The Jackson Laboratory) mice with B6.Cg-Gt(ROSA)26 Sortm14(CAG-tdTomato)Hze /J (Ai14: RRID: IMSR_JAX: 007914; stock no. 007914; The Jackson Laboratory) mice. This breeding scheme allows for the visualization of the red fluorescent protein tdTomato in Cre-expressing CRF cells [42,43]. Details of their characterization and validation has been published [42,43].

    • Corticotropin releasing factor neurons in the visual cortex mediate long-term changes in visual function induced by early adversity

      2022, Neurobiology of Stress
      Citation Excerpt :

      These studies can shed light upon future studies on the underlying mechanisms. Stress does not increase the number of PVN CRF-positive neurons but only increases their activity (Walker et al., 2019; Wamsteeker Cusulin et al., 2013). Thus, we speculate that ECMS did not change CRF-positive cell numbers in the visual cortex during development.

    • Organisation of enkephalin inputs and outputs of the central nucleus of the amygdala in mice

      2022, Journal of Chemical Neuroanatomy
      Citation Excerpt :

      Sections were then transferred to the primary solution (see Table 1 for concentrations), diluted in blocking solution overnight. Sections were then washed in 0.1 M PBS (3 ×5 min) before being transferred to a secondary antibody solution (See Table 2 for details and concentration) diluted in blocking solution for 2 h. Sections were washed in 0.1 M PBS (3 × 5 min), directly mounted onto slides, and cover slipped with DAKO fluorescence mounting medium (Agilent Technologies) (Ch'ng et al., 2019; Walker et al., 2019; Walker et al., 2019, 2021) To map out the efferent and afferent connectome of CeAENK neurons, immunoamplification of endogenous GFP was conducted (Table 1). To determine putative synaptic inputs in efferent targets, endogenous mRuby was visualised.

    • Role of CRF<inf>1</inf> and CRF<inf>2</inf> receptors in the lateral hypothalamus in cardiovascular and anxiogenic responses evoked by restraint stress in rats: Evaluation of acute and chronic exposure

      2022, Neuropharmacology
      Citation Excerpt :

      The corticotropin-releasing factor (CRF), acting as a neurotransmitter in the brain, has been shown to regulate responses independent of the hypothalamus-pituitary-adrenal (HPA) axis, including the cardiovascular and behavioral changes to systemic and psychological stressors (Deussing and Chen, 2018). In this sense, expression of both CRF1 and CRF2 receptors and CRF neurons (Bittencourt et al., 1999; Chalmers et al., 1995; Van Pett et al., 2000; Walker et al., 2019), as well as CRF inputs from limbic structures (Deussing and Chen, 2018; Giardino et al., 2018; Marcinkiewcz et al., 2016; Pomrenze et al., 2015) were identified within the LH. Besides, previous studies indicated that neuronal activation in the LH evoked by restraint stress was decreased in CRF1 receptor knock-out mice (Winsky-Sommerer et al., 2004) and microinjection of a selective CRF1 receptor antagonist into the LH dose-dependently decreased the tachycardic response evoked by acute restraint stress (Barretto-de-souza et al., 2021).

    View all citing articles on Scopus
    View full text